SUMMARY In this study we found that, in 31 normal subjects, close to 90% of circulating arginine vasopressin (AVP), measured by radiolmmunoassay, was associated with platelets. By using routine methods of centrifugation, which do not completely separate platelets, the normal range of plasma vasopressin was higher by twofold than the normal range in platelet-free plasma prepared by differential centrifugation, which was 1.4 ± 1.0 SD pg/ml. Platelet vasopressin was 12.9 ± 5.7 pg/ml. Patients with congestive heart failure had, on average, an elevated platelet-free plasma AVP, as did two patients with thrombocytopenia and one with thrombocytosis. Patients with essential hypertension had slightly high levels of platelet-free plasma AVP and demonstrated an abnormal inverse relationship between platelet-free plasma AVP and serum osmolality. Immunoreactive platelet vasopressin was slightly low in patients with essential hypertension and was subnormal in patients with congestive heart failure. These studies demonstrate that platelets normally present in centrifuged plasma cause an overestimation of the plasma vasopressin levels. Until the physiological meaning of plasma and platelet-bound AVP is understood, studies of circulating vasopressin should probably assess both plasma and platelet AVP levels. 2 Moreover, vasopressin is reported to be involved in various forms.of experimental hypertension, 1 * 9 and lesions of the medulla oblongata have been shown to cause excessive release and acute hypertension. 10 In addition, elevations of urine and plasma vasopressin have been reported in some patients with hypertension"" 13 despite the presence of lower serum sodium.
SUMMARY In this study we found that, in 31 normal subjects, close to 90% of circulating arginine vasopressin (AVP), measured by radiolmmunoassay, was associated with platelets. By using routine methods of centrifugation, which do not completely separate platelets, the normal range of plasma vasopressin was higher by twofold than the normal range in platelet-free plasma prepared by differential centrifugation, which was 1.4 ± 1.0 SD pg/ml. Platelet vasopressin was 12.9 ± 5.7 pg/ml. Patients with congestive heart failure had, on average, an elevated platelet-free plasma AVP, as did two patients with thrombocytopenia and one with thrombocytosis. Patients with essential hypertension had slightly high levels of platelet-free plasma AVP and demonstrated an abnormal inverse relationship between platelet-free plasma AVP and serum osmolality. Immunoreactive platelet vasopressin was slightly low in patients with essential hypertension and was subnormal in patients with congestive heart failure. These studies demonstrate that platelets normally present in centrifuged plasma cause an overestimation of the plasma vasopressin levels. Until the physiological meaning of plasma and platelet-bound AVP is understood, studies of circulating vasopressin should probably assess both plasma and platelet AVP levels. (Hypertension 5 (supp I): I-129-I-138, 1983) KEY WORDS • congestive heart failure arginine vasopressin thrombocytopenia • antldiuretic hormone A RGININE vasopressin is a potent vasoconstrictor and antidiuretic hormone. Experimentally, it has been implicated in the maintenance of normal blood pressure during dehydration 1 and during renin and norepinephrine blockade. 2 Moreover, vasopressin is reported to be involved in various forms.of experimental hypertension, 1 * 9 and lesions of the medulla oblongata have been shown to cause excessive release and acute hypertension. 10 In addition, elevations of urine and plasma vasopressin have been reported in some patients with hypertension"" 13 despite the presence of lower serum sodium. 13 On the other hand, the role of vasopressin in the maintenance of hypertension is controversial, 14 " 17 and there is evidence to suggest that vasopressin cannot maintain chronic hypertension because of a compen-Nonetheless, measurements of circulating vasopressin in human hypertension may be of value by providing clues to underlying mechanisms. Vasopressin is released into the circulation in response to either osmotic stimuli or volume-dependent baroreceptor-mediated stimuli. 20 " 23 Therefore, assessment of vasopressin levels in relation to serum osmolality should provide evidence of which mechanism is operative in patients who have abnormal levels of vasopressin.
In the present study we evaluated arginine vasopressin (AVP) levels in relation to the serum osmolality, in a group of untreated patients with essential hypertension. In the course of this investigation, using a sensitive radioimmunoassay method for vasopressin, 24 we observed abnormally high levels in plasma samples that were contaminated with the buffy coat. We then found that vasopressin levels measured in a platelet fraction were close to tenfold higher than in plateletfree plasma and, that platelet-free plasmas had significantly lower values than in most previous reports. 22 In this paper we report these findings and also the results of vasopressin measurements in platelets and platelet- 1-130   1982 BLOOD PRESSURE COUNCIL SUPP I, HYPERTENSION, VOL 5, No 2, MARCH-APRIL 1983 free plasma from hypertensive patients, in patients with congestive heart failure and in three patients with abnormalities in their platelet count. renin groups by relating the plasma renin level to the concurrent 24-hour urinary sodium excretion and comparing it to a nomogram derived from normal subjects as previously described.
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Methods
Human Subjects
Forty normal healthy volunteers (16 men and 24 women) and 31 patients participated in this study. Oral consent was obtained from all. Of the 40 normal subjects, 31 were used to define the normal range of platelet-free plasma and platelet AVP, and nine provided blood for the other studies. Twenty untreated hypertensive patients (11 males and nine females, mean age 51 years) had established essential hypertension (mean blood pressure 169/104 mm Hg ± 23/10 SD). The patients had either never been treated or had been withdrawn from antihypertensive medication at least 3 weeks prior to study. Two female patients were also studied who had thrombocytopenia, one male with thrombocytosis, and one female with orthostatic hypotension.
Eight additional patients (six male and two female, mean age 59 years) had chronic congestive heart failure (CHF) with functional class III or IV symptomatology by the New York Heart Association classification. All diuretic therapy had been discontinued in these patients for at least 4 days prior to blood sampling and patients were on a 100 mEq sodium diet. All previous vasodilator therapy had likewise been discontinued for at least 4 days, but six of the eight patients were maintained on a daily dose of digoxin ranging from 0.125 to 0.25 mg. Digoxin was not administered on the moming of the blood sampling. The severity of congestive heart failure was documented by invasive hemodynamic studies on the morning of AVP blood sampling. These studies revealed the following mean hemodynamic values: cardiac index, 2.01 ± 0.17 liter/min/m 2 (normal 3.20 ± 0.06 liter/min/m 2 ); left ventricular filling pressure, 24 ± 2 mm Hg (normal 8 ± 4 mm Hg); and systemic vascular resistance of 1683 ± 173 dynes-sec-cm" 5 (normal 1200 ± 300 dynes -sec -cm" 5 ). Four of the eight patients had samples drawn on a second occasion when they had been switched to a 10 mEq sodium diet. One patient had sampling during the occurrence of orthostatic hypotension during head-up tilt, as explained in the text.
Blood samples for measurement of vasopressin, renin activity, 25 electrolytes, and osmolality were collected in the morning, usually between 10 a.m. and 12 a.m., from seated subjects (except patients with CHF who were supine) who had been previously ambulatory for at least 2 hours. Subjects were requested to refrain from cigarette smoking and coffee drinking prior to blood drawing. Subjects collected a 24-hour urine specimen immediately prior to blood drawing, which was used for measurement of sodium and potassium excretion.
Hypertensive patients, maintaining a random sodium intake, were subdivided into low, normal, and high Processing of Blood for Vasopressin Assay Two 10 ml samples of blood were collected into K 2 EDTA Vacutainers. In the initial studies, blood was centrifuged at 4°C or at room temperature for 20 minutes at 2500 rpm (1500 g). In later studies we collected platelets and plasma separately using differential centrifugation at 25°C; 10 ml of blood was centrifuged for 10 minutes at 950 rpm (140 g) to obtain platelet-rich plasma (PRP). This was then centrifuged in 1 ml samples at 25°C for 15 minutes at 15,000 rpm (25,000 g; Sorvall centrifuge Model RC, Ivan Sorvall, Inc., Norwalk, Connecticut) to obtain platelets and platelet-free plasma (PFP). Standard plasma, PFP, and platelets were stored at -40°C, usually for less than 2 weeks, and for a maximum of 4 months prior to assay.
Measurement of Vasopressin by Radioimmunoassay
Plasma AVP was measured using the method of Cowley et al., 24 with slight modifications. Highly specific antibodies were kindly provided by Dr. Cowley. These antibodies did not cross-react with oxytocin, angiotensin I, angiotensin II, and bradykinin in concentrations of 0-1000 pg/ml, but 38.9% cross-reactivity was observed with lysine-vasopressin. 24 In this method proteins from 1 ml of plasma (in duplicate) were precipitated by the addition of 2 ml acetone. The proteins were removed by centrifugation, and the supernatant evaporated to dryness in a rotary evaporator (Savant, Model-SVC 200H, Savant Instruments, Inc., Hicksville, New York). We dissolved the samples in 0.2 ml water and 0.25 ml of 0.15 M phosphate buffer, pH7.3, containing 0.01 M Na 2 EDTA, 0.02 M L-cystine, 0.1 mM neomycin sulfate, 0.01 M e-aminocaproic acid, and 0.1% bovine serum albumin. One set of standards (in duplicate) in 0.1% BSA in 0.9% NaCl were subjected to the same precipitation procedure. Following evaporation, the standards were dissolved in 0.2 ml water and 0.25 ml of the same phosphate buffer adjusted to pH 8.0 with 2N NaOH. (The difference in buffer pH ensured that plasma and standards were adjusted to the same final pH.). Antibody was added to the deproteinated standards, to the unknowns, and to a second set of standards. The tubes were allowed to equilibrate for 24 hours at 4°C prior to the addition of I25 I AVP. Equilibration was continued for an additional 48 hours at 4°C, after which time antibody-bound AVP was separated from free AVP by the addition of 0.25 ml of 1.6% dextran-coated charcoal. Both bound and free AVP were counted, and the AVP level of unknown samples was obtained by extrapolation from the extracted standard curve.
For quality control, two plasma samples containing two different concentrations of exogenous AVP PLATELET VAS0PRESS1N IN HYPERTENSION/Pmb/sz et al.
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(stored in 1 ml aliquots at -40°C) were assayed in duplicate with each set. As reported by Cowley et al. , 24 the nonspecific binding (NSB; i.e., that fraction of the total I23 I AVP that is not adsorbed by charcoal in the absence of antibody) tends to be lower in the absence of plasma (3.9% ± 0.3% instead of 5.0% ± 0.3%). However, we did not observe differences in NSB between individual human plasmas in 74 samples assayed. Also, the NSB of platelets was similar to that of platelet-free plasma (5.0% ± 0.2% vs 4.7% ± 0.4%). Therefore, to reduce the volume of plasma needed for each assay to 2 ml, we routinely measured NSB only in the two plasmas that were routinely assayed with each set, and subtracted that value from the bound counts of each unknown plasma and platelets.
In our laboratory the sensitivity of the assay was 0.5 pg/ml; the interassay and intraassay reproducibility was 16.5% and 9% respectively. Recovery of 26 pg vasopressin added to 1 ml of whole blood was 57.8% ± 5.2% at 4°C and 53.7% ± 9.9% at room temperature.
Platelets
The platelet pellet from 1 ml of platelet-rich plasma was suspended in 0.9 ml of freshly prepared 0.1% bovine serum albumin in isotonic saline. This suspension was precipitated with 2 ml acetone (as described above) and the supernatant evaporated to dryness and redissolved in 0.2 ml water plus 0.25 ml of the phosphate buffer at pH 8.0. The remainder of the assay was the same as for plasma. The results are expressed as pg AVP in platelets from 1 ml of platelet-rich plasma.
Osmolality
Serum osmolality was determined in duplicate by freezing point depression (Digimatic osmometer Model 3D11, Advanced Instruments, Inc., Needham Heights, Massachusetts). The coefficient of variation of multiple determinations was 0.2%. The reproducibility of 12 samples measured twice within weeks was 1.2%.
Platelet Count
Platelets were measured in a Coulter Counter (Model P-64, Coulter Electronics Inc., Edison, New York).
Results
Methodological Considerations
In the initial studies, AVP was measured in 12 plasmas prepared from blood that was centrifuged by the standard method of centrifugation (i.e., 2500 rpm) at either 4° or 25°C. AVP was consistently higher in plasma processed at 25°C [2.9 ± 1.5(sD)cf 1.6 ± 1.3 pg/ml; p < 0.001]. Despite this difference, we found no further change in the level of AVP if the plasma samples were allowed to incubate at either 4° or 25°C for 5 hours. There have been reports that vasopressin is unstable in blood at ambient temperature. 27 However, we and others 28 have been unable to confirm this.
To investigate why plasma centrifuged at 25°C should have higher levels than plasma centrifuged at 4°C, we collected 10 ml blood samples from five normal subjects using either K 2 EDTA or heparin as anticoagulant and centrifuged them at either 4°C (EDTA and heparin) or 25°C (EDTA) for 20 minutes at 2500 rpm. Each milliliter of plasma was removed separately from the top to the middle of the tube ( fig. 1) . The sixth or deepest plasma sample was usually contaminated by buffy coat and by some red cells. In each of the first 4 ml of plasma, AVP levels were very low, ranging from 0 to 1.0 pg/ml. Neither the anticoagulant nor the temperature of processing affected the results. The fifth milliliter occasionally exhibited higher values, while AVP levels in the sixth sample averaged close to tenfold higher (p < 0.001) ( fig. 1) .
To investigate which blood element was responsible for the increased vasopressin in the 6th sample, we prepared platelet-rich plasma by differential centrifugation (see Methods) and found that it contained abnormally high levels of AVP. The red cell fraction also had higher AVP levels than plasma, but this could be accounted for by contamination with platelets. We then counted the number of platelets remaining in plasma separated by the standard centrifugation method (i.e., 2500 rpm for 20 minutes) and found that 4% to 10% of the platelets remained in such plasma and that there were more platelets left in plasma centrifuged at room temperature than in plasma centrifuged at 4°C, (35,700 ± 4800 and 15,200 ± 1000 per pil respectively, n = 22, p < 0.001). Thus, a higher degree of platelet contamination explains our original observation that plasma centrifuged at room temperature had slightly higher AVP levels. The mean vasopressin level in plasma centrifuged at 2500 rpm at 4°C from 13 normal subjects (seven males, six females) was higher than that found in platelet-free plasma from 31 different normal subjects (13 males, 18 females) [2.4 ± 0.3 pg/ml cf. 1.4 ± 0.2 pg/ml, p < 0.005]. Therefore, in all future studies vasopressin was measured in duplicate 1 ml samples of platelet-free plasma (separated by differential centrifugation) and in the platelets separated from duplicate 1 ml samples of platelet-rich plasma.
Radioimmunoassay Characteristics of Platelet Vasopressin-Like Material
Two different types of study were carried out on 50 ml of blood collected from each of two volunteers. In the first approach (A, table 1) platelets from 8 x l m l of platelet-rich plasma were suspended in 1 ml of 0.9% saline and then extracted and reconstituted using the routine method. Following reconstitution, diminishing volumes of this extract were assayed in duplicate. In the second approach (B, table 1) platelets derived from different volumes of platelet-rich plasma were suspended in 1 ml of 0.9% saline and then extracted and reconstituted using the routine method.
The results demonstrate that, irrespective of whether different numbers of platelets were extracted or whether different volumes of extract were assayed, the amount of vasopressin-like material measured was similar and proportional to the volume assayed.
In another attempt to evaluate whether the substance on the platelets was AVP, Dr. A Sved (Department of Neurology, Cornell University Medical College, New York, New York) assayed three different volumes of extract in duplicate using a different source of antibodies and a different method. 29 He found 0.6, 1.2, and 2.5 pg AVP in 5, 10, and 20 /xl of extract, thus demonstrating both detectability and linearity of the vasopressin-like material in a different RIA. tEach result is expressed as total pg AVP per sample and represents the mean of duplicate assays.
Plasma and Platelet Vasopressin in Normal Subjects
In 31 normal subjects, platelet AVP averaged 12.9 ± 1.0 (SE) pg/ml while plasma AVP was only 1.4 ± 0.2 pg/ml. Platelet AVP was higher than plasma AVP in every subject (p < 0.001) ( fig. 2 ). There were no differences in the platelet level between males [13.4 ± 1.0 pg/ml] and females (12.5 ± 1.1 pg/ml), but females (none of whom was on oral contraceptives) had significantly higher plasma AVP levels than males (p < 0.001) ( fig. 3) . Mean values for plasma AVP were 0.7 ± 0.1 pg/ml for males and 1.9 ± 0.2 for females. The total AVP in plasma and platelets was almost equal in females and males, 14.4 ± 1.2 and 14.1 ± 2.0 pg/ml respectively. Among normal subjects there was no relationship between plasma and platelet AVP levels (r = 0.01). On average, only 10.6% ± 1.6% of AVP was free in the plasma and almost 90% was bound to the platelets.
Serum osmolality in the normal subjects averaged 289.3 ± 0.8 mOsm/liter (table 2). There was no difference between males (288.9 ± 1.3 mOsm/liter) and females (288.6 ± l.OmOsm/liter). The rate of urinary sodium excretion was not different between males (131 ± 16 mEq/24 hours) and females (124 ± 17 mEq/24 hours) and neither was the urinary sodium concentration 140 ± 15 vs 125 ± 14 mEq/liter respectively. In the group as a whole, there was a direct relationship between serum osmolality and AVP that was significant for platelets (r = 0.55, p < 0.01) but not for plasma (r = 0.26) (fig. 4) . 
Plasma and Platelet AVP in Hypertensive Patients
In 20 patients with essential hypertension, plasma vasopressin was significantly elevated compared to normal individuals, 2.3 ± 0.3 pg/ml vs 1.4 ± 0.2 (p < 0.01), whereas platelet AVP was lower, 9.3 ± 0.9 vs 12.9 ± 1.0 pg/m (p < 0.01) ( fig. 5 and table  2 ). There was no difference in the platelet counts of platelet-rich plasma between normal and hypertensive subjects (463,250 ± 6100and431,270 ± 35,3OO//A1). Only hypertensive males had plasma vasopressin levels that were elevated and this was because the normal range for males was lower than that of females ( fig. 3  and table 2 ). Platelet vasopressin was on average lower than normal for both males and females ( fig. 3) . The total plasma and platelet AVP was significantly lower in hypertensives, 11.5 ± 0.9 pg/ml than in normal subjects, 14.3 ± 1.0 (p < 0.05), so that the fraction of vasopressin that was free in the plasma was 22.2% (21% ± 3.5% in males and 24.3% ± 5.4% in fe- males, n.s.) and was more than double that found in normal persons, which was 10.6% (5.4% ± 1.1% in males and 14.4% ± 2.2% in females, p < 0.01).
There was no significant difference in serum osmolality between normals and hypertensives (table 2). In contrast to the normotensives, there was no relationship between platelet AVP and serum osmolality for the hypertensives but there was a highly significant inverse relationship between plasma AVP and serum osmolality (r = -0.14,p < 0.001) (fig. 4) . The four patients who had serum osmolality below 285 mOsm/ liter and plasma AVP above 3 pg/ml all had high renin. None of them had elevated platelet AVP ( fig. 4) Plasma and Platelet AVP in Congestive Heart Failure In thirteen studies in eight patients with congestive heart failure, plasma AVP levels were abnormally high, 4.9 ± 0.9 pg/ml (p < 0.001) and the platelet AVP was lower than in normal subjects, 7.8 ± 0.9 pg/ ml (p < 0.001) ( fig. 5 ). Total vasopressin was not different from normal (12.7 ± 1.2forCHF vs 14.3 ± 1.0 pg/ml). However, the free plasma AVP was 38.6% of the total, four times higher than that found in normal subjects. Serum osmolality was on average lower than in the normals (284.8 ± 2.9 vs 289.3 ± 0.8 mOsm/ liter (p < 0.05). Patients with Abnormal Platelet Count Plasma AVP was above the normal range in two patients with thrombocytopenia (platelet counts were 5900 and 14,000 per (JL\) and in one patient with thrombocytosis (platelet count 2,500,000 per ^tl). There was no vasopressin in the platelet fraction of the patients with thrombocytopenia. Very high levels of AVP (45 pg/ml) were associated with the platelets of the thrombocytotic patient. However, if the platelet count had been normal the platelet AVP would have been 9 pg/ ml, a value which falls within the normal range (see fig. 5 ).
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Relationship between Plasma and Platelet Vasopressin
To evaluate whether vasopressin added to whole blood is taken up by the platelets 13 pg vasopressin were added to 10 ml of whole blood at 4°C and separation of the platelets by differential centrifugation was begun either within 5 minutes or after 3 hours at 4°C. For the 5-minute samples (n = 5), there was no difference in platelet AVP as compared to that found in platelets from control blood which had not received any exogenous AVP ( fig. 6 ). In contrast, each sample that was incubated for 3 hours demonstrated an increase in platelet AVP over control. On average, there was an increase of 2.1 ± 0.5 pg/ml; thus, 16% of the exogenous AVP was taken up by the platelets. We also examined the dynamics of the relationship of plasma to platelet AVP in two patients who had marked changes in circulating AVP (associated with a vasovagal reaction) in response to tilt ( fig. 7) . Patient 1 had orthostatic hypotension while Patient 2 had congestive heart failure. In both patients, plasma AVP increased markedly, and this was associated with a smaller but definite rise in platelet AVP. Patient 2 was followed for 2 hours after the initial tilt study and then tilted again (this time during converting enzyme blockade). During the time between the tilts, the plasma AVP level fell back toward baseline while the platelet level remained elevated. During the second tilt, both plasma and platelet AVP increased again to similar degrees as the first time. These preliminary observations suggest that AVP increases first in the plasma and is shortly thereafter taken up by the platelets. The platelet-bound pool of AVP appears to decay more slowly than plasma AVP.
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Discussion
In this report we have demonstrated that vasopressin, as characterized immunoreactively, occurs in human plasma largely bound to platelets. The concentration in the platelet fraction averaged close to ten times that found in plasma. We have also shown that plasma that is centrifuged at 2500 rpm for 20 minutes at 4°C still contains approximately 4% of the platelets which results in an overestimation of the plasma level of vasopressin. Plasma contaminated with buffy coat can have artifactually very high levels of plasma vasopressin.
When platelets were more completely removed from plasma by differential centrifugation we found that the normal range of plasma vasopressin was lower than in plasma centrifuged by the standard technique and was lower than most reported values. Thus, our normal range was 1.4 ± 1.0 (SD) pg/ml. There was no apparent change in plasma vasopressin with age, but males had lower values (0.71 ± 0.48 pg/ml) than females (2.25 ± 1.3 pg/ml). There was no detectable reason for this sex difference. Serum osmolality was identical in the males and females and plasma renin activity was also not different (table 2) . There was also no evidence that the lower plasma vasopressin level in normal males affected the reabsorption of water by the kidney since the urinary sodium concentration divided by the 24 hour sodium excretion was the same in males and females (table 2) .
The reason for the lack of a relationship between plasma osmolality and platelet-free plasma AVP in the normal subjects is unclear. It is possible that the range of osmolality was too narrow in the normals (283 to 300 mOsm/liter) and the number of subjects too small to reveal the previously reported relationship between serum osmolality and AVP. 20 In addition future studies will be required to explain the inverse relationship between serum osmolality and plasma AVP in the hypertensive patients and the slightly elevated plasma AVP levels in some of the hypertensive patients. It is noteworthy that four of the five hypertensive patients with plasma AVP above 3.0 pg/ml had serum osmolality below 285 mOsm/L and they also had high renin. Therefore, the elevated AVP may be explained by a direct effect of angiotensin II on vasopressin release, 30 or they may have elevated serum-ionized calciums leading to increased vasopressin release, 3132 or they may have slightly contracted blood volumes leading to a baroreceptor-mediated signal for renin release, as has been suggested for patients with cirrhosis. 33 Whatever the mechanism for the slightly higher plasma vasopressin levels in the hypertensive patients, it was clearly not increased osmolality.
As reported by others who measured AVP in normally processed plasma, 34 -35 platelet-free plasma vasopressin was elevated in patients with congestive heart failure. As a group they had lower serum osmolality than normals, again suggesting perhaps a volume-mediated stimulus for vasopressin release.
At this time we have not definitively identified the vasopressin like substance from platelets as arginine vasopressin but several observations suggest that it is likely to be. Thus it behaved like vasopressin in the RIA in that different concentrations displaced I23 I AVP from AVP antibodies in a manner than paralleled that of standard AVP. This was true whether different volumes of platelets were extracted and then assayed or different volumes of extract were assayed, making it PLATELET VASOPRESSIN IN HYPERTENSION/ZVe/fcuz et al.
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unlikely that a protease present in the platelet extract interferes with the assay. It also occurred using a different antibody and assay 29 carried out by A. Sved, Ph.D., of the Department of Neurology. Also, exogenous AVP added to whole blood was taken up by the platelets (fig. 6 ), and when plasma AVP increased markedly in two patients during a vasovagal reaction following tilt, the platelet level also increased ( fig. 7) . The presence of vasopressin on platelets is also consistent with the report of Berrettini et al. 36 who found that platelets have vasopressin receptors with binding characteristics similar to those reported for renal tissue. 37 Nonetheless, all of these pieces of evidence are circumstantial, and other studies will be required to definitively identify and also to explain the role of platelet vasopressin.
There does not appear to be a simple direct relationship between plasma and platelet AVP levels. In response to acute stimuli, both plasma and platelet AVP seem to increase together and plasma AVP increases much more than platelet AVP ( fig. 7) . On the other hand, groups of patients who have high plasma vasopressin tend to have lower platelet vasopressin levels. This holds for normals, hypertensives, and patients with congestive heart failure ( fig. 5 ). It is therefore likely that changes in the binding characteristics of AVP to platelets occur under demand situations.
The findings to date make it difficult to establish whether it is the free plasma vasopressin, the bound vasopressin or both which are involved in mediating its physiologic actions. There is evidence to suggest that it is the free plasma vasopressin that is biologically relevant because this value correlates closely, but inversely with serum osmolality in patients with essential hypertension. In addition, free plasma vasopressin is slightly high in hypertensive patients and is elevated in patients with CHF.
On the other hand, there is also evidence to suggest that the vasopressin bound to platelets is biologically important. Thus, free plasma vasopressin was elevated in patients with thrombocytopenia. Second, in certain situations where the free vasopressin is increased, the amounts bound to platelets may be reduced (e.g., essential hypertension and CHF). Third, there are reports that vasopressin induces platelet aggregation, although the amounts that cause this effect are much higher than we have detected on the platelets. 38 Until the physiological meaning of the free and platelet-bound circulating moieties of vasopressin is fully understood, studies of the role of circulating vasopressin in cardiovascular homeostasis and in cardiovascular diseases should probably assess the possible influence of each of these two circulating vasopressin pools.
